arginine and alpha-Galactosidase A Deficiency

arginine has been researched along with alpha-Galactosidase A Deficiency in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19902 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imai, H; Kitagawa, W; Komatsuda, A; Miura, N; Nishikawa, K; Suzuki, K; Suzuki, S; Watanabe, D1
Roth, J; Yam, GH; Zuber, C1
Holcenberg, JS1
Batshaw, ML; Braine, H; Brusilow, SW; Moser, HW; Murray, C1

Reviews

1 review(s) available for arginine and alpha-Galactosidase A Deficiency

ArticleYear
Progressive renal failure despite long-term biweekly enzyme replacement therapy in a patient with Fabry disease secondary to a new α-galactosidase mutation of Leu311Arg (L311R).
    Clinical and experimental nephrology, 2011, Volume: 15, Issue:6

    Topics: Adult; alpha-Galactosidase; Arginine; Biopsy; Disease Progression; DNA Mutational Analysis; Drug Administration Schedule; Enzyme Replacement Therapy; Fabry Disease; Glomerular Filtration Rate; Humans; Isoenzymes; Kidney; Leucine; Male; Mutation; Recombinant Proteins; Renal Insufficiency; Time Factors; Treatment Outcome

2011

Other Studies

3 other study(ies) available for arginine and alpha-Galactosidase A Deficiency

ArticleYear
A synthetic chaperone corrects the trafficking defect and disease phenotype in a protein misfolding disorder.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2005, Volume: 19, Issue:1

    Topics: 1-Deoxynojirimycin; alpha-Galactosidase; Amino Acid Substitution; Animals; Arginine; Cells, Cultured; Fabry Disease; Fibroblasts; Glutamine; Humans; Lysosomes; Mice; Mice, Transgenic; Molecular Chaperones; Mutation; Phenotype; Protein Binding; Protein Folding; Protein Transport; Trihexosylceramides

2005
Enzyme therapy: problems and solutions.
    Annual review of biochemistry, 1982, Volume: 51

    Topics: Animals; Arginine; Blood Coagulation Disorders; Enzyme Therapy; Enzymes; Enzymes, Immobilized; Erwinia; Escherichia coli; Fabry Disease; Folic Acid; gamma-Glutamyl Hydrolase; Gaucher Disease; Humans; Hydrogen-Ion Concentration; Kinetics; Lysosomes; Metabolic Clearance Rate; Neoplasms; Poisoning; Ribonucleases; Urokinase-Type Plasminogen Activator

1982
Management of heritable disorders of the urea cycle and of Refsum's and Fabry's diseases.
    Progress in clinical and biological research, 1979, Volume: 34

    Topics: Adult; Amino Acid Metabolism, Inborn Errors; Arginine; Benzoates; Carbamoyl-Phosphate Synthase (Ammonia); Dietary Proteins; Fabry Disease; Hippurates; Humans; Male; Nitrogen; Ornithine Carbamoyltransferase Deficiency Disease; Phytanic Acid; Plasmapheresis; Refsum Disease; Trihexosylceramides; Urea

1979